IMGT Co.,Ltd. (XKON: 456570)

Market Cap	60.67B
Revenue	n/a
Net Income	n/a
Shares Out	4.76M
EPS	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	217
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	5,900 - 26,500
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About IMGT Co.,Ltd.

IMGT Co.,Ltd. engages in researching and developing of an ultrasound-guided therapy technology for genetic therapy and drug delivery systems. It develops IMGT-LPS, a technology that injects ultrasound-sensitive nanoparticles in the form of liposome-wrapped pharmacological substances into the body and releases drugs by irradiating ultrasound to the target area(tumor); IMGT-EMB, a nanoparticle for chemoembolization of liver cancer; IMGT-TSD, a targeted sonodynamic therapy that induces immune boosting mechanism by applying ultrasonic stimulation t...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2010
• Country: South Korea
• Stock Exchange: Korea New Exchange
• Ticker Symbol: 456570